213 related articles for article (PubMed ID: 29472618)
21. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
22. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
[TBL] [Abstract][Full Text] [Related]
23. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
24. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
25. The circulating immunoglobulins negatively impact on the parasite clearance in the liver of Leishmania donovani-infected mice via dampening ROS activity.
Srinontong P; Wu Z; Sato K; Nagaoka H; Maekawa Y
Biochem Biophys Res Commun; 2018 Nov; 506(1):20-26. PubMed ID: 30336975
[TBL] [Abstract][Full Text] [Related]
26. Differential Role of Leptin as an Immunomodulator in Controlling Visceral Leishmaniasis in Normal and Leptin-Deficient Mice.
Maurya R; Bhattacharya P; Ismail N; Dagur PK; Joshi AB; Razdan K; McCoy JP; Ascher J; Dey R; Nakhasi HL
Am J Trop Med Hyg; 2016 Jul; 95(1):109-119. PubMed ID: 27114296
[TBL] [Abstract][Full Text] [Related]
27. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
[TBL] [Abstract][Full Text] [Related]
28. STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis.
Oghumu S; Gupta G; Snider HM; Varikuti S; Terrazas CA; Papenfuss TL; Kaplan MH; Satoskar AR
Eur J Immunol; 2014 Feb; 44(2):450-9. PubMed ID: 24242758
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
30. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
[TBL] [Abstract][Full Text] [Related]
31. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
32. Combination of
Dey S; Mukherjee D; Sultana SS; Mallick S; Dutta A; Ghosh J; Hussain A; Sarkar B; Mandal S; Patra P; Saha B; Pal C
Infect Immun; 2020 May; 88(6):. PubMed ID: 32229617
[TBL] [Abstract][Full Text] [Related]
33. The Absence of HIF-1α Increases Susceptibility to Leishmania donovani Infection via Activation of BNIP3/mTOR/SREBP-1c Axis.
Mesquita I; Ferreira C; Moreira D; Kluck GEG; Barbosa AM; Torrado E; Dinis-Oliveira RJ; Gonçalves LG; Beauparlant CJ; Droit A; Berod L; Sparwasser T; Bodhale N; Saha B; Rodrigues F; Cunha C; Carvalho A; Castro AG; Estaquier J; Silvestre R
Cell Rep; 2020 Mar; 30(12):4052-4064.e7. PubMed ID: 32209468
[TBL] [Abstract][Full Text] [Related]
34. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
Singh N; Sundar S
PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
[TBL] [Abstract][Full Text] [Related]
35. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
36. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
[TBL] [Abstract][Full Text] [Related]
37. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar.
Ghosh M; Mandal L; Maitra S; Rakshit S; Paul K; Bagchi J; Ganguly D; Pal C; Bandyopadhyay S
J Infect Dis; 2006 Aug; 194(3):294-301. PubMed ID: 16826476
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo immunomodulatory properties of octyl-β-D-galactofuranoside during Leishmania donovani infection.
Guegan H; Ory K; Belaz S; Jan A; Dion S; Legentil L; Manuel C; Lemiègre L; Vives T; Ferrières V; Gangneux JP; Robert-Gangneux F
Parasit Vectors; 2019 Dec; 12(1):600. PubMed ID: 31870416
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.
Gorak PM; Engwerda CR; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):687-95. PubMed ID: 9521079
[TBL] [Abstract][Full Text] [Related]
40. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
